Prestige BioPharma Limited (KRX:950210)
12,030
-180 (-1.47%)
At close: Jan 16, 2026
-20.07% (1Y)
| Market Cap | 144.59B |
| Revenue (ttm) | 14.41B |
| Net Income (ttm) | 15.76B |
| Shares Out | 12.02M |
| EPS (ttm) | 262.37 |
| PE Ratio | 45.85 |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 133,655 |
| Average Volume | 142,062 |
| Open | 12,210 |
| Previous Close | 12,210 |
| Day's Range | 11,910 - 12,210 |
| 52-Week Range | 11,000 - 20,000 |
| Beta | 0.97 |
| RSI | 39.12 |
| Earnings Date | Feb 27, 2026 |